Nascent Biotech Inc. Contracts & Agreements
15 Contracts & Agreements
- Business Finance (14 contracts)
- Business Operations (1)
- Convertible Debenture (Filed With SEC on September 28, 2022)
- NASCENT BIOTECH, INC. CONVERTIBLE DEBENTURE (Filed With SEC on September 20, 2022)
- Convertible Debenture (Filed With SEC on September 9, 2022)
- Securities Purchase Agreement (Filed With SEC on September 9, 2022)
- Securities Purchase Agreement (Filed With SEC on September 9, 2022)
- Registration Rights Agreement (Filed With SEC on September 9, 2022)
- Convertible Debenture (Filed With SEC on September 2, 2022)
- Securities Purchase Agreement (Filed With SEC on September 2, 2022)
- Securities Purchase Agreement (Filed With SEC on September 2, 2022)
- Registration Rights Agreement (Filed With SEC on September 2, 2022)
- Stock purchase agreement (Filed With SEC on January 8, 2021)
- Stock purchase agreement (Filed With SEC on December 31, 2020)
- Research Collaboration Agreement between Nascent Biotech Inc. and Manhattan BioSolutions, Inc. dated April 30, 2020 (Filed With SEC on May 14, 2020)
- Common Stock Purchase Agreement (Filed With SEC on September 6, 2019)
- Registration Rights Agreement (Filed With SEC on September 6, 2019)
